NASDAQ
Dianthus Therapeutics, Inc. (DNTH) has a free cash flow growth of 38.74% as of Friday, May 29, 2026. This represents a 324.36% increase compared to its 12-month average of -17.27%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.